Related Experiment Video
Updated: Aug 16, 2026

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Intramuscular midazolam vs intravenous diazepam for acute seizures
1Department of Pediatrics, Seth G.S. Medical College & KEM Hospital, Parel, Mumbai, India. irashah86@hotmail.com.
Insights
Intramuscular midazolam effectively controls acute seizures in children, acting faster than intravenous diazepam, especially for febrile convulsions. This method offers a safer alternative with fewer side effects, particularly for patients with difficult intravenous access.
Area of Science:
- Pediatric Emergency Medicine
- Clinical Pharmacology
Background:
- Acute seizures in children pose a significant clinical challenge.
- Intravenous diazepam is a common treatment but requires established intravenous access.
- Alternative routes of administration are needed for efficient seizure control.
Purpose of the Study:
- To compare the effectiveness of intramuscular midazolam versus intravenous diazepam for controlling acute seizures in children.
- To evaluate the onset of action and side effect profiles of both treatment modalities.
Main Methods:
- A randomized study involving 115 children (1 month to 12 years) with acute convulsions.
- Patients without IV access received either intramuscular midazolam or intravenous diazepam.
- Time to seizure cessation and adverse events were recorded and compared.
Main Results:
- Intramuscular midazolam demonstrated a significantly faster onset of action (97.22 seconds) compared to intravenous diazepam (250.35 seconds in patients without prior IV access).
- Midazolam was effective across various age groups, seizure types, and etiologies, particularly in febrile convulsions.
- No side effects were observed with intramuscular midazolam, whereas 10.8% of patients receiving intravenous diazepam experienced thrombophlebitis.
Conclusions:
- Intramuscular midazolam is a highly effective first-line agent for managing acute seizures in children, offering rapid seizure control.
- It presents a safer alternative to intravenous diazepam, with a notable absence of side effects and is particularly advantageous for children lacking immediate intravenous access.
Objective:
To determine effectiveness of intramuscular midazolam to control acute seizures in children as compared to intravenous diazepam.
Methods:
115 children in the age group of 1 month to 12 years who presented with acute convulsions were enrolled in the study. Patients who already had an intravenous access present were treated intravenous diazepam. Patients without an i.v. access at the time of convulsions were randomised into 2 groups and treated with either intramuscular midazolam or intravenous diazepam for control of seizures. Time interval from administration of drug to cessation of seizures was compared. Effectiveness of i.m. midazolam in various age groups, types of convulsions and etiology of convulsions was analyzed. Side effects of both drugs were evaluated.
Results:
The mean interval to cessation of convulsions with i.m. midazolam was 97.22 seconds whereas in diazepam group without prior i.v. access it was 250.35 seconds and in diazepam group with prior i.v. access it was 119.4 seconds. i.m. midazolam acted faster in all age groups and in patients with febrile convulsions, which was statistically significant. i.m. midazolam was equally effective in various types of convulsions be it GTC or focal convulsions. 7 patients (10.8%) had thrombophlebitis associated with i.v. diazepam administration whereas none of the patients in the midazolam group had any side effects, which was statistically significant.
Conclusion:
i.m. midazolam is an effective agent for controlling acute convulsions in children especially in children with febrile convulsions. It has relatively no side effects as compared to Intravenous diazepam and can be used as a first line agent for treatment of acute convulsions in patients with difficult intravenous access.
More Related Videos
Related Concept Videos
Parenteral Anesthetics: Overview
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Skeletal Muscle Relaxants: Therapeutic Uses
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...

